Acute Treatment of Atrial Flutter: Ibutilide, Transesophageal Pacing, or DC Shock?

  • M. Disertori
Conference paper


Drug therapy with class IA and IC antiarrhythmic agents has proven relatively disappointing for the termination of atrial flutter. Unike all other agents, ibutilide, a new pure class III agent, is more effective in patients with atrial flutter than in patients with atrial fibrillation.


Atrial Fibrillation Atrial Flutter Electrical Cardioversion Sick Sinus Syndrome Effective Refractory Period 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ellenbogen KA, Stambler BS, Wodd MA et al (1996) Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and flutter: a dose-response study. J Am Coll Cardiol 28:130–136PubMedCrossRefGoogle Scholar
  2. 2.
    Stambler BS, Wodd MA, Ellenbogen KA et al (1996) Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 94:1613–1621PubMedCrossRefGoogle Scholar
  3. 3.
    Murray KT (1998) Ibutilide. Circulation 97:493–497PubMedCrossRefGoogle Scholar
  4. 4.
    Sotalol Comparator Study (1996) (protocol 0019) Corvert injection (ibutilide fumarate) Comprehensive review. Appendix I. Pharmacia and Upjohn, KalamazooGoogle Scholar
  5. 5.
    Volgman AS, Stambler BS, Kappagoda C (1996) Comparative efficacy of intravenous Ibutilide versus Procainamide for rapid termination of atrial fibrillation or flutter. Pacing Clin Electrophysiol 9(II):608 (abstr)Google Scholar
  6. 6.
    Inoue H, Yamashita T, Nozaki A et al (1991) Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol 18:1098–1104PubMedCrossRefGoogle Scholar
  7. 7.
    Disertori M (1993) La stimolazione atriale transesofagea nel trattamento del flutter atriale: utilità e limiti. G Ital Cardiol 23:281–283PubMedGoogle Scholar
  8. 8.
    Disertori M, Inama G, Vergara G et al (1984) Impiego della stimolazione atriale transesofagea nel trattamento del flutter atriale. G Ital Cardiol 14:153–159PubMedGoogle Scholar
  9. 9.
    Guarnerio M, Furlanello F, Del Greco M et al (1989) Transesophageal atrial pacing: a first-choice technique in atrial flutter therapy. Am Heart J 117:1241–1252PubMedCrossRefGoogle Scholar
  10. 10.
    Doni F, Delia Bella P, Kheir A et al (1995) Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone. Am J Cardiol 76:1243–1246PubMedCrossRefGoogle Scholar
  11. 11.
    Stambler BS, Wood MA, Ellenbogen KA (1996) Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by overdrive pacing. Am J Cardiol 77:960–966PubMedCrossRefGoogle Scholar
  12. 12.
    Olshansky B, Kerber RE (1996) Cardioversion of atrial flutter. In: Waldo AL, Touboul P (eds) Atrial flutter: advances in mechanisms and management. Futura, Armonk NY, pp 366–409Google Scholar
  13. 13.
    Zarkin GA, Bala MV, Calingaert B et al (1998) The cost-effectiveness of Ibutilide versus electrical cardioversion in the treatment of atrial fibrillation and flutter. Am J Managed Care 22:211–224Google Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • M. Disertori
    • 1
  1. 1.Divisione di CardiologiaOspedale S. ChiaraTrentoItaly

Personalised recommendations